Osteoarthritis Research Society International (OARSI) World Congress

May 06, 2019

OARSI 2019: Today―in the era of shared decision making and patient-centered care―patient preferences should be incorporated into clinical practice.

May 06, 2019

OARSI 2019:  Readmission rates for joint surgery patients are down in Ontario where post-surgery in hospital stays have been shortened.

May 06, 2019

OARSI 2019:  Osteoarthritis of the hands may be more widespread than previously thought.

May 06, 2019

OARSI 2019: Phase IIIb clinical trial for the extended release injectable triamcinolone acetonide (Zilretta, Flexion) shows improvement in pain, stiffness and function. 

May 06, 2019

OARSI 2019:  Using a cane may not foster the growth of medial tibiofemoral bone marrow lesions (BML) in knee osteoarthritis.

May 06, 2019

OARSI 2019:  Men and women with a mother or sibling who have osteoarthritis, have an increased risk of osteoarthritis in the hips, knees and hands.

May 06, 2019

OARSI 2019:  Half of opioid prescriptions made today are not aligned with treatment guidelines.

May 03, 2019

Half of opioid prescriptions made today are not aligned with treatment guidelines, say researchers reporting this weekend in Toronto at the Osteoarthritis Research Society International (OARSI) World Congress on Osteoarthritis. In this slideshow, we highlight this and other presentations made at the meeting on Friday.

April 06, 2016

Spanish researchers have uncovered evidence that may be indicative of solid biomarkers for osteoarthritis. Researchers reported their findings at the OARSI 2016 World Congress held in Amsterdam this month.

April 05, 2016

Vitamin D doesn't offer much osteoarthritis pain relief. Knee pain, physical function, bone marrow lesions and effusion-synovitism show little improvements, shows a study presented at OARSI 2016.